Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | TABLET;ORAL | 5MG | 0 | DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE |
002 | TABLET;ORAL | 10MG | 0 | DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE |
FDA Submissions
| ORIG | 1 | AP | 2002-01-29 | |
LABELING; Labeling | SUPPL | 4 | AP | 2007-08-31 | |
LABELING; Labeling | SUPPL | 5 | AP | 2008-02-06 | |
LABELING; Labeling | SUPPL | 6 | AP | 2010-04-29 | |
LABELING; Labeling | SUPPL | 8 | AP | 2015-01-29 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2015-04-17 | STANDARD |
LABELING; Labeling | SUPPL | 14 | AP | 2016-10-28 | STANDARD |
LABELING; Labeling | SUPPL | 16 | AP | 2017-01-04 | STANDARD |
LABELING; Labeling | SUPPL | 22 | AP | 2022-02-25 | STANDARD |
Submissions Property Types
SUPPL | 8 | Null | 15 |
SUPPL | 10 | Null | 7 |
SUPPL | 14 | Null | 15 |
SUPPL | 16 | Null | 15 |
SUPPL | 22 | Null | 7 |
TE Codes
001 | Prescription | AA |
002 | Prescription | AA |
CDER Filings
SPECGX LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 40436
[companyName] => SPECGX LLC
[docInserts] => ["",""]
[products] => [{"drugName":"DEXTROAMPHETAMINE SULFATE","activeIngredients":"DEXTROAMPHETAMINE SULFATE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"DEXTROAMPHETAMINE SULFATE","activeIngredients":"DEXTROAMPHETAMINE SULFATE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"DEXTROAMPHETAMINE SULFATE","submission":"DEXTROAMPHETAMINE SULFATE","actionType":"5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"DEXTROAMPHETAMINE SULFATE","submission":"DEXTROAMPHETAMINE SULFATE","actionType":"10MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)